ltrasound-guided Hyaluronic acid injection in Trapeziometarcarpal joint arthritis: a triple blind, randomised clinical trial of efficacy and safety
Not Applicable
- Conditions
- Trapeziometarcarpal joint arthritis
- Registration Number
- TCTR20201221005
- Lead Sponsor
- lerdsin hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- nknown
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Trapeziometarcarpal joint arthritis Eaton stage 1-3
Exclusion Criteria
1.history inflammation arthritis, infection
2.previous thumb base trauma
3.patient who coagulation disorder, treat anticoagulants,treat antiplatelet drugs
4.skin disease
5.known allergy eggs, feathers, avian, proteins or HA
6.pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pain score 4,12,24 weeks after injection Visual analog scale
- Secondary Outcome Measures
Name Time Method disabilities of the arm, shoulder, and hand 4,12,24 weeks after injection quickDASH score